Funicular Funds, LP
CIK 1937147 · last filed 2023-10-13
Funicular Funds, LP is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for LITS, was dated Jul 23, 2025. Across all open-market trades the lifetime net is +$658.7K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
4
$658.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Lite Strategy, Inc. (MEIP) Delisted | 10%+ Owner | 490,840 | $3.20 | $1.57M | $658.7K | 2 | 2023-10-13 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | 10%+ Owner | 430,076 | $28.80 | $12.39M | $0 | 1 | 2022-07-08 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-23 | LITS | Notice (144) | −611,440 | -$3.79M | EDGAR |
| 2023-10-13 | Lite Strategy, Inc. (MEIP) Delisted | Exer (X) | +90,000 | $630.0K | EDGAR |
| 2023-09-25 | Lite Strategy, Inc. (MEIP) Delisted | Mixed | +96,120 | $658.7K | EDGAR |
| 2022-07-08 | Oruka Therapeutics, Inc. (ABIO) Delisted | Other (J) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.